{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:06:53Z","timestamp":1791893213198,"version":"4.3.4"},"reference-count":48,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Toxoplasma gondii, the causative agent of toxoplasmosis, is a protozoan parasite capable of infecting a wide range of hosts, posing significant health risks, particularly to immunocompromised individuals and congenital transmission. Current therapeutic options primarily target the active tachyzoite stage but are limited by issues such as toxicity and incomplete efficacy. As a result, there is an urgent need for alternative therapies that can selectively target parasite-specific mechanisms critical for metabolic processes and host\u2013parasite interactions. In this context, \u03b1-carbonic anhydrase (Tg_CA), an enzyme essential for T. gondii survival has emerged as a promising drug target. Tg_CA was successfully expressed and purified to evaluate its susceptibility to sulfonamide-based inhibitors, represented by compounds 1\u201324 and the AAZ\u2013HCT series. These inhibitors demonstrated a broad spectrum of activity, with KI values ranging from 17.8 to 8450 nM. Several compounds exhibited moderate to high potency against Tg_CA; however, concerns regarding selectivity arose because of the inhibition of human isoforms, particularly CA I and CA II. Thus, although some inhibitors showed strong activity against Tg_CA, optimizing selectivity remains crucial for minimizing off-target effects and improving therapeutic efficacy. Further structural modifications may enhance selectivity and advance the development of effective treatments for toxoplasmosis.<\/jats:p>","DOI":"10.3390\/ijms26010116","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T19:33:07Z","timestamp":1735241587000},"page":"116","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring the Inhibition of Toxoplasma gondii \u03b1-Carbonic Anhydrase by Sulfonamides: Insights into Potential Drug Targeting"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0669-7481","authenticated-orcid":false,"given":"Simone","family":"Giovannuzzi","sequence":"first","affiliation":[{"name":"Neurofarba Department, Section of Pharmaceutical Sciences, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-833X","authenticated-orcid":false,"given":"Viviana","family":"De Luca","sequence":"additional","affiliation":[{"name":"Department of Biology, Agriculture and Food Sciences, National Research Council (CNR), Institute of Biosciences and Bioresources, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3314-2411","authenticated-orcid":false,"given":"Clemente","family":"Capasso","sequence":"additional","affiliation":[{"name":"Department of Biology, Agriculture and Food Sciences, National Research Council (CNR), Institute of Biosciences and Bioresources, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[{"name":"Neurofarba Department, Section of Pharmaceutical Sciences, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Vilela, V.L.R., and Feitosa, T.F. (2024). Recent Advances in Toxoplasma gondii Infection and Toxoplasmosis. Trop. Med. Infect. Dis., 9.","DOI":"10.3390\/tropicalmed9070160"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s40001-024-02055-4","article-title":"Trend in serological and molecular diagnostic methods for Toxoplasma gondii infection","volume":"29","author":"Kim","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.sjbs.2020.11.007","article-title":"Toxoplasmosis: Stages of the protozoan life cycle and risk assessment in humans and animals for an enhanced awareness and an improved socio-economic status","volume":"28","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e00037","DOI":"10.1016\/j.fawpar.2019.e00037","article-title":"Toxoplasma gondii infection and toxoplasmosis in farm animals: Risk factors and economic impact","volume":"15","author":"Stelzer","year":"2019","journal-title":"Food Waterborne Parasitol."},{"key":"ref_5","first-page":"496","article-title":"Clinical outcomes of pediatric patients with congenital toxoplasmosis in a fourthlevel center Introduction. Congenital","volume":"44","author":"Marino","year":"2024","journal-title":"Biomedica"},{"key":"ref_6","unstructured":"Madireddy, S., and Mangat, R. (2024). Toxoplasmosis, StatPearls."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/archdischild-2018-316603","article-title":"Fifteen-minute consultation: Management of the infant born to a mother with toxoplasmosis in pregnancy","volume":"105","author":"Saso","year":"2020","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pt.2006.01.007","article-title":"Toxoplasmosis: Beyond animals to humans","volume":"22","author":"Sukthana","year":"2006","journal-title":"Trends Parasitol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1128\/AAC.42.6.1346","article-title":"Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group","volume":"42","author":"Torre","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","first-page":"1253","article-title":"Disseminated toxoplasmosis confirmed by tachyzoites and cysts in bone marrow smear after cord blood transplantation","volume":"65","author":"Sasaki","year":"2024","journal-title":"Rinsho Ketsueki"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e00057-17","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.47936\/encephalitis.2022.00115","article-title":"The use of azithromycin and pyrimethamine for treatment of cerebral toxoplasmosis in human immunodeficiency virus-infected patients: A systematic review","volume":"3","author":"Ramos","year":"2023","journal-title":"Encephalitis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e00036","DOI":"10.1016\/j.fawpar.2019.e00036","article-title":"Treatment of toxoplasmosis: Current options and future perspectives","volume":"15","author":"Konstantinovic","year":"2019","journal-title":"Food Waterborne Parasitol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13543776.2023.2205586","article-title":"The management of Babesia, amoeba and other zoonotic diseases provoked by protozoa","volume":"33","author":"Capasso","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Vermelho, A.B., and Supuran, C.T. (2022). Challenges and promises for obtaining new antiprotozoal drugs: What\u2019s going wrong?. Antiprotozoal Drug Development and Delivery, Springer Nature.","DOI":"10.1007\/7355_2021_136"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Renzi, G., Ladu, F., Carta, F., and Supuran, C.T. (Arch. Pharm. Weinheim, 2024). The carbonic anhydrase enzymes as new targets for the management of neglected tropical diseases, Arch. Pharm. Weinheim, in press.","DOI":"10.1002\/ardp.202400626"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.jinf.2013.09.023","article-title":"It is not only the cat that did it: How to prevent and treat congenital toxoplasmosis","volume":"68","year":"2014","journal-title":"J. Infect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10096-008-0612-5","article-title":"Role of spiramycin\/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy","volume":"28","author":"Valentini","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.43.9.2240","article-title":"Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis","volume":"43","author":"Nikolic","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"26538","DOI":"10.1074\/jbc.270.44.26538","article-title":"Enoyl-Acyl Carrier Protein Reductase (Fabi) Plays a Determinant Role in Completing Cycles of Fatty-Acid Elongation in Escherichia-Coli","volume":"270","author":"Heath","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"30804","DOI":"10.1074\/jbc.M703178200","article-title":"The Farnesyl-diphosphate\/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates","volume":"282","author":"Ling","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00436-018-6027-z","article-title":"Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review","volume":"117","author":"Montazeri","year":"2018","journal-title":"Parasitol. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e00051-18","DOI":"10.1128\/AAC.00051-18","article-title":"Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift Assays","volume":"62","author":"Scheele","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2346523","DOI":"10.1080\/14756366.2024.2346523","article-title":"Cloning, expression, and purification of an alpha-carbonic anhydrase from Toxoplasma gondii to unveil its kinetic parameters and anion inhibition profile","volume":"39","author":"Giovannuzzi","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13543776.2023.2201432","article-title":"Antiprotozoal drugs: Challenges and opportunities","volume":"33","author":"Supuran","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1517\/14728222.2015.1067685","article-title":"Bacterial, fungal and protozoan carbonic anhydrases as drug targets","volume":"19","author":"Capasso","year":"2015","journal-title":"Expert Opin. Ther. Tar."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s13071-020-04445-z","article-title":"The life-cycle of Toxoplasma gondii reviewed using animations","volume":"13","author":"Attias","year":"2020","journal-title":"Parasit. Vectors"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Huynh, M.H., and Carruthers, V.B. (2022). Toxoplasma gondii excretion of glycolytic products is associated with acidification of the parasitophorous vacuole during parasite egress. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010139"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1017\/S0031182020000207","article-title":"Computational approaches for drug discovery against trypanosomatid-caused diseases","volume":"147","author":"Pereira","year":"2020","journal-title":"Parasitology"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Roiko, M.S., Svezhova, N., and Carruthers, V.B. (2014). Acidification Activates Toxoplasma gondii Motility and Egress by Enhancing Protein Secretion and Cytolytic Activity. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004488"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13071-024-06213-9","article-title":"Lipid metabolism: The potential targets for toxoplasmosis treatment","volume":"17","author":"He","year":"2024","journal-title":"Parasit. Vectors"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e00027-17","DOI":"10.1128\/mSphere.00027-17","article-title":"A Glycosylphosphatidylinositol-Anchored Carbonic Anhydrase-Related Protein of Is Important for Rhoptry Biogenesis and Virulence","volume":"2","author":"Chasen","year":"2017","journal-title":"Msphere"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/jm4000616","article-title":"Cloning, characterization, and sulfonamide and thiol inhibition studies of an alpha-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease","volume":"56","author":"Pan","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1021\/jm400418p","article-title":"A class of sulfonamides with strong inhibitory action against the alpha-carbonic anhydrase from Trypanosoma cruzi","volume":"56","author":"Akdemir","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1021\/jm400902y","article-title":"Design, Synthesis, and Evaluation of Hydroxamic Acid Derivatives as Promising Agents for the Management of Chagas Disease","volume":"57","author":"Rodrigues","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Jaitak, A., Kumari, K., Kounder, S., and Monga, V. (2024). Carbonic anhydrases: Moiety appended derivatives, medicinal and pharmacological implications. Bioorg. Med. Chem., 114.","DOI":"10.1016\/j.bmc.2024.117933"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Angeli, A., Kartsev, V., Petrou, A., Lichitsky, B., Komogortsev, A., Geronikaki, A., and Supuran, C.T. (2023). Substituted furan sulfonamides as carbonic anhydrase inhibitors: Synthesis, biological and in silico studies. Bioorg. Chem., 138.","DOI":"10.1016\/j.bioorg.2023.106621"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Angeli, A., Paoletti, N., and Supuran, C.T. (2023). Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors. Molecules, 28.","DOI":"10.3390\/molecules28073220"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: Advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic Local Alignment Search Tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J. Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Del Prete, S., Vullo, D., Ghobril, C., Hitce, J., Clavaud, C., Marat, X., Capasso, C., and Supuran, C.T. (2019). Cloning, Purification, and Characterization of a beta-Carbonic Anhydrase from Malassezia restricta, an Opportunistic Pathogen Involved in Dandruff and Seborrheic Dermatitis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102447"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3109\/14756366.2012.703185","article-title":"Biochemical properties of a novel and highly thermostable bacterial \u03b1-carbonic anhydrase from","volume":"27","author":"Capasso","year":"2012","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"ref_46","unstructured":"Lineweaver, H. (1985). Citation Classic\u2014The Determination of Enzyme Dissociation-Constants. Curr. Contents Life Sci., 19."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-6147(93)90070-Z","article-title":"The Cheng-Prusoff Relationship\u2014Something Lost in the Translation","volume":"14","author":"Craig","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1021\/acsinfecdis.1c00055","article-title":"Structure-Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae","volume":"7","author":"Hewitt","year":"2021","journal-title":"ACS Infect. Dis."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/1\/116\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:00:44Z","timestamp":1760115644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/1\/116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["ijms26010116"],"URL":"https:\/\/doi.org\/10.3390\/ijms26010116","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]}}}